GILD vs SCNI
Gilead Sciences, Inc. - Common Stock · Scinai Immunotherapeutics Ltd. - American Depositary Shares
Relative return (rebased to 100)
Key stats
| Metric | GILD | SCNI |
|---|---|---|
| Price | $146.12 | $3.22 |
| Market Cap | $181.42B | $44.67B |
| P/E | 21.32 | — |
| P/B | 7.71 | 5512.86 |
| P/S | 6.16 | 34073.79 |
| ROE | 36.2% | -102.5% |
| Net Margin | 28.9% | -633.6% |
| Gross Margin | — | -202.3% |
| Revenue Growth | 2.4% | 99.2% |
| Dividend Yield | 2.16% | — |
| EPS | $6.85 | -$0.00 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.